Cormorant Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-267,500	Closed	-$21.3M	–	87
2022 Q2	$21.3M	Buy	267,500 +167,500	+168%	+$13.4M	1.61%	21
2022 Q1	$10.5M	Buy	+100,000	New	+$10.5M	0.81%	38